Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M.,
Singh added that results from the ongoing FOCUS studya long-term ophthalmic endpoint trial evaluating semaglutide versus placebo in patients with type 2 diabeteswill be critical in clarifying the long-term retinal safety profile of GLP-1 therapies
The distinction matters: Visceral fat drives insulin resistance and cardiovascular risk Lean mass supports metabolic rate, insulin sensitivity, and physical function Muscle preservation is associated with better long-term weight maintenance Published research consistently associates resistance training and adequate protein intake (the International Society of Sports Nutrition recommends 1.42.0 g/kg/day for exercising individuals during energy restriction ISSN Position Stand) with better lean mass preservation during weight loss from any cause
More Than a ProductA Movement Start with products you believe in
Safety and Side Effects While Semaglutide is generally well-tolerated, its important to be aware of potential side effects
